banner

Posts tagged as: ADVENTRX stock chart back to homepage

ADVENTRX Pharmaceuticals Stock Chart Analysis Video ADVENTRX Pharmaceuticals Stock Chart Analysis Video(0)

The ADVENTRX Pharmaceuticals Inc. (AMEX:ANX) stock chart is holding a solid support level at $0.56 and climbing again towards the upper portion of a multi-month channel with resistance at 67 cents. Volume has remained consistent, but technical traders will be looking for a surge to take out the top of the channel with the next resistance not until 81 cents. On a pullback, the bottom support must hold for the stock chart to remain in play. Read More

OTCBB News

Arthritis Foundation to Distribute Pacific Shore’s Thermal Aid Bears for Kids Arthritis Foundation to Distribute Pacific Shore’s Thermal Aid Bears for Kids(0)
Rarus Inks Deal for Social Media Augmented Reality Software Rarus Inks Deal for Social Media Augmented Reality Software(0)
West Point Places Order with Intergetics West Point Places Order with Intergetics(0)
CrowdGather: Capitalize on the Silent Majority CrowdGather: Capitalize on the Silent Majority(0)
GelTech Receives First Order for FireIce from Turkey GelTech Receives First Order for FireIce from Turkey(0)
Lyris to Host Third Quarter Earnings Webcast Lyris to Host Third Quarter Earnings Webcast(0)
read more


Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Gateways

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories
Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.